6-169704059-C-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The ENST00000339209.9(PHF10):āc.1441G>Cā(p.Ala481Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000042 in 1,430,170 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: not found (cov: 33)
Exomes š: 0.0000042 ( 0 hom. )
Consequence
PHF10
ENST00000339209.9 missense
ENST00000339209.9 missense
Scores
11
8
Clinical Significance
Conservation
PhyloP100: 3.31
Genes affected
PHF10 (HGNC:18250): (PHD finger protein 10) This gene contains a predicted ORF that encodes a protein with two zinc finger domains. The function of the encoded protein is not known. Sequence analysis suggests that multiple alternatively spliced transcript variants are derived from this gene but the full-length nature of only two of them is known. These two splice variants encode different isoforms. A pseudogene for this gene is located on Xq28. [provided by RefSeq, Jul 2008]
C6orf120 (HGNC:21247): (chromosome 6 open reading frame 120) This gene encodes a conserved, N-glycosylated protein that likely functions in the cellular response to endoplasmic reticulum stress. This protein is able to induce apoptosis in vitro in CD4+ T-cells. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.31462377).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PHF10 | NM_018288.4 | c.1441G>C | p.Ala481Pro | missense_variant | 12/12 | ENST00000339209.9 | NP_060758.2 | |
C6orf120 | NM_001029863.3 | c.*1024C>G | 3_prime_UTR_variant | 1/1 | ENST00000332290.4 | NP_001025034.1 | ||
PHF10 | NM_133325.3 | c.1435G>C | p.Ala479Pro | missense_variant | 12/12 | NP_579866.2 | ||
C6orf120 | NM_001317342.2 | c.*1024C>G | 3_prime_UTR_variant | 2/2 | NP_001304271.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PHF10 | ENST00000339209.9 | c.1441G>C | p.Ala481Pro | missense_variant | 12/12 | 1 | NM_018288.4 | ENSP00000341805 | ||
PHF10 | ENST00000621772.4 | c.1300G>C | p.Ala434Pro | missense_variant | 12/12 | 1 | ENSP00000484117 | P1 | ||
C6orf120 | ENST00000332290.4 | c.*1024C>G | 3_prime_UTR_variant | 1/1 | NM_001029863.3 | ENSP00000346931 | P1 | |||
PHF10 | ENST00000366780.8 | c.1435G>C | p.Ala479Pro | missense_variant | 12/12 | 5 | ENSP00000355743 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome AF: 0.00000420 AC: 6AN: 1430170Hom.: 0 Cov.: 30 AF XY: 0.00000422 AC XY: 3AN XY: 711122
GnomAD4 exome
AF:
AC:
6
AN:
1430170
Hom.:
Cov.:
30
AF XY:
AC XY:
3
AN XY:
711122
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 03, 2024 | The c.1441G>C (p.A481P) alteration is located in exon 12 (coding exon 12) of the PHF10 gene. This alteration results from a G to C substitution at nucleotide position 1441, causing the alanine (A) at amino acid position 481 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D
M_CAP
Benign
D
MetaRNN
Benign
T;T;T
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
.;M;.
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;.
REVEL
Uncertain
Sift
Benign
T;T;.
Sift4G
Benign
T;T;T
Polyphen
P;B;.
Vest4
MutPred
0.56
.;Gain of glycosylation at A481 (P = 0.0025);.;
MVP
MPC
0.62
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at